Skip to main content
Figure 2 | Molecular Cancer

Figure 2

From: Sodium glucose cotransporter 1 ligand BLF501 as a novel tool for management of gastrointestinal mucositis

Figure 2

Treatment with BLF501 maintained normal levels of beta-catenin expression in the small intestine of mice treated with a single dose of DXR. Immunohistochemical analysis of beta-catenin: (A, B) UNTR, untreated; (C, D) BLF501 25 μg/kg; (E, F) DXR + 5-FU 48 h; (G, H) DXR + 5-FU + BLF501 25 μg/kg 48 h; (I, J) DXR + 5-FU 72 h; (K, L) DXR + 5-FU + BLF501 25 μg/kg 72 h. Bars: 20 μm. Experiments were performed in triplicate.

Back to article page